180 related articles for article (PubMed ID: 36132083)
1. Regulatory Role of B Cells and Its Subsets in Hepatitis E Virus Infection.
Sharma M; Tripathy AS
Biomed Res Int; 2022; 2022():7932150. PubMed ID: 36132083
[TBL] [Abstract][Full Text] [Related]
2. IL-10-producing regulatory B-cells suppressed effector T-cells but enhanced regulatory T-cells in chronic HBV infection.
Liu Y; Cheng LS; Wu SD; Wang SQ; Li L; She WM; Li J; Wang JY; Jiang W
Clin Sci (Lond); 2016 Jun; 130(11):907-19. PubMed ID: 26980345
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-35 promotes Breg expansion and interleukin-10 production in CD19
Zhang Y; Wei S; Wu Q; Shen X; Dai W; Zhang Z; Chen M; Huang H; Ma L
Clin Rheumatol; 2022 Aug; 41(8):2403-2416. PubMed ID: 35420296
[TBL] [Abstract][Full Text] [Related]
4. Deficit of circulating CD19
Zaimoku Y; Patel BA; Kajigaya S; Feng X; Alemu L; Quinones Raffo D; Groarke EM; Young NS
Br J Haematol; 2020 Aug; 190(4):610-617. PubMed ID: 32311088
[TBL] [Abstract][Full Text] [Related]
5. TGF-β
Rathod SB; Tripathy AS
Hum Immunol; 2016 Dec; 77(12):1254-1263. PubMed ID: 27720959
[TBL] [Abstract][Full Text] [Related]
6. Comparison of peripheral blood B cell subset ratios and B cell-related cytokine levels between ocular and generalized myasthenia gravis.
Hu Y; Wang J; Rao J; Xu X; Cheng Y; Yan L; Wu Y; Wu N; Wu X
Int Immunopharmacol; 2020 Mar; 80():106130. PubMed ID: 31978800
[TBL] [Abstract][Full Text] [Related]
7. Impaired function of CD19(+) CD24(hi) CD38(hi) regulatory B cells in patients with pemphigus.
Zhu HQ; Xu RC; Chen YY; Yuan HJ; Cao H; Zhao XQ; Zheng J; Wang Y; Pan M
Br J Dermatol; 2015 Jan; 172(1):101-10. PubMed ID: 24935080
[TBL] [Abstract][Full Text] [Related]
8. CD24
Xu C; Zhang M; Li K; Ni M; Bai Y; Zhang J; Song X; Wang J
Int Immunopharmacol; 2019 May; 70():295-301. PubMed ID: 30851710
[TBL] [Abstract][Full Text] [Related]
9. CD19
Chen Q; Lai L; Chi X; Lu X; Wu H; Sun J; Wu W; Cai L; Zeng X; Wang C; Chen W; Peng A
Mediators Inflamm; 2020; 2020():3019378. PubMed ID: 32104147
[TBL] [Abstract][Full Text] [Related]
10. Regulatory B Cells Dysregulated T Cell Function in an IL-35-Dependent Way in Patients With Chronic Hepatitis B.
Liu Y; Luo Y; Zhu T; Jiang M; Tian Z; Tang G; Liang X
Front Immunol; 2021; 12():653198. PubMed ID: 33912178
[TBL] [Abstract][Full Text] [Related]
11. Purification and Immunophenotypic Characterization of Human CD19
Bradford HF; Mauri C
Methods Mol Biol; 2021; 2270():77-90. PubMed ID: 33479894
[TBL] [Abstract][Full Text] [Related]
12. PD-L1
Zacca ER; Onofrio LI; Acosta CDV; Ferrero PV; Alonso SM; Ramello MC; Mussano E; Onetti L; Cadile II; Stancich MI; Taboada Bonfanti MC; Montes CL; Acosta Rodríguez EV; Gruppi A
Front Immunol; 2018; 9():2241. PubMed ID: 30327652
[No Abstract] [Full Text] [Related]
13. Peripheral regulatory cells immunophenotyping in primary Sjögren's syndrome: a cross-sectional study.
Furuzawa-Carballeda J; Hernández-Molina G; Lima G; Rivera-Vicencio Y; Férez-Blando K; Llorente L
Arthritis Res Ther; 2013; 15(3):R68. PubMed ID: 23800367
[TBL] [Abstract][Full Text] [Related]
14. Elevated circulating CD19
Deng B; Deng L; Liu M; Zhao Z; Huang H; Tu X; Liang E; Tian R; Wang X; Wang R; Lin H; Yu Y; Peng A; Xu P; Bao K; He M
Immunol Lett; 2023 Sep; 261():58-65. PubMed ID: 37553031
[TBL] [Abstract][Full Text] [Related]
15. Reduced CD5(+) CD24(hi) CD38(hi) and interleukin-10(+) regulatory B cells in active anti-neutrophil cytoplasmic autoantibody-associated vasculitis permit increased circulating autoantibodies.
Aybar LT; McGregor JG; Hogan SL; Hu Y; Mendoza CE; Brant EJ; Poulton CJ; Henderson CD; Falk RJ; Bunch DO
Clin Exp Immunol; 2015 May; 180(2):178-88. PubMed ID: 25376552
[TBL] [Abstract][Full Text] [Related]
16. Frequency of CD19
Zhao Q; Jung LK
Pediatr Rheumatol Online J; 2018 Jul; 16(1):44. PubMed ID: 29973221
[TBL] [Abstract][Full Text] [Related]
17. Regulatory B cells (CD19(+)CD38(hi)CD24(hi)) in alloimmunized and non-alloimmunized children with β-thalassemia major.
Zahran AM; Elsayh KI; Saad K; Embaby M; Ali AM
Blood Cells Mol Dis; 2016 Mar; 57():91-6. PubMed ID: 26852663
[TBL] [Abstract][Full Text] [Related]
18. Restoration of regulatory B cell deficiency following alemtuzumab therapy in patients with relapsing multiple sclerosis.
Kim Y; Kim G; Shin HJ; Hyun JW; Kim SH; Lee E; Kim HJ
J Neuroinflammation; 2018 Oct; 15(1):300. PubMed ID: 30373595
[TBL] [Abstract][Full Text] [Related]
19. Decreased IL-10-producing regulatory B cells in patients with advanced mycosis fungoides.
Akatsuka T; Miyagaki T; Nakajima R; Kamijo H; Oka T; Takahashi N; Suga H; Yoshizaki A; Asano Y; Sugaya M; Sato S
Eur J Dermatol; 2018 Jun; 28(3):314-319. PubMed ID: 29952298
[TBL] [Abstract][Full Text] [Related]
20. Loss of Gαq impairs regulatory B-cell function.
He Y; Yuan X; Li Y; Zhong C; Liu Y; Qian H; Xuan J; Duan L; Shi G
Arthritis Res Ther; 2018 Aug; 20(1):186. PubMed ID: 30143054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
